Exact Sciences and Pfizer Extend and Amend Cologuard® Promotion Agreement
MADISON, Wis. and NEW YORK, Oct. 7, 2020 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) and Pfizer Inc. (NYSE: PFE) today announced an extension and amendment of their agreement to promote Cologuard, the first and only FDA-approved non-invasive stool DNA screening test for colorectal...